Showing Results for: “diabetes exercise”

Today, the American Diabetes Association ® (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) published a joint consensus report addressing diabetes management in chronic kidney disease (CKD). A joint writing group of ADA and KDIGO representatives reviewed and developed a series of consensus statements that provide clear direction for implementation of care to improve clinical outcomes for people with diabetes and CKD. The organizations aligned in areas of CKD screening and diagnosis, glycemia monitoring, lifestyle therapies, treatment goals, and pharmacologic management. “It is

Raghuram Nagarathna, MD, FRCP, DSc, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Vivian Fonseca and Nagendran Family Diabetes Research Award. This award, given in memory of Mr. P. Nagendran, promotes and recognizes diabetes research focused on the South Asian, Asian American, Native Hawaiian and Pacific Islander populations, and/or research by a scientist from these areas. The Award honors the contributions of Dr. Vivian Fonseca, a former ADA President, Medicine & Science and the Tullis-Tulane Alumni Chair in Diabetes, Professor of Medicine Chief in the

The American Diabetes Association® (ADA) will present the 2019 Outstanding Educator in Diabetes Award to Virginia Valentine, APRN, BC-ADM, CDE, FAADE. This award recognizes a distinguished health professional who has made outstanding educational efforts in the field of diabetes and has demonstrated significant contributions to the understanding of diabetes education. Ms. Valentine will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. She will deliver her Outstanding Educator in Diabetes Award Lecture

The American Diabetes Association® (ADA) will present the 2019 Outstanding Achievement in Clinical Diabetes Research Award to John B. Buse, MD, PhD. This award recognizes exceptional contributions in patient-oriented or clinical outcomes research that have had a significant impact on diabetes prevention and treatment. Dr. Buse will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. Dr. Buse is the Verne S. Caviness Distinguished Professor, Chief of the Division of Endocrinology, Director of the Diabetes

As Puerto Rico, U.S. Virgin Islands, Florida and Georgia brace for Tropical Storm Dorian, a potential category 2 hurricane, that is currently expected to make landfall early between Thursday and Friday, the diabetes community is rallying to make sure that people living with diabetes—especially those who depend upon insulin—are fully supported. The Diabetes Disaster Response Coalition (DDRC) , which is comprised of the nation’s leading diabetes organizations, is urging all people with diabetes and their loved ones to prepare by putting together a diabetes kit and making a plan to stay healthy

Abbott is committing $5 million over three years to the American Diabetes Association (ADA) to help close the health disparities gap for underserved diabetes communities, especially people of color and lower-income Americans Today, Abbott and the American Diabetes Association® (ADA) announced that Abbott has become the first anchor sponsor of the Health Equity Now (HEN) platform to address health disparities for people with diabetes. Abbott’s sponsorship includes a three-year, $5 million commitment to support the ADA's advocacy and community-driven projects aimed at removing barriers to care

The American Diabetes Association® (ADA) will present the 2019 Outstanding Physician Clinician in Diabetes Award to David C. Klonoff, MD, FACP, FRCP Edin, Fellow AIBME. Presented annually, the award honors praiseworthy contributions to diabetes clinical practice. Dr. Klonoff will be recognized with this honor at the National Scientific and Health Care Awards Presentation on Monday, June 10, during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. Dr. Klonoff is Medical Director of the Diabetes Research Institute at Mills-Peninsula Medical

Community program seeks to understand how to increase access to health technology for underserved diabetes communities Abbott and the American Diabetes Association ® (ADA) announced today the launch of their first joint community health partnership. The community initiative, which is the first program under the ADA's Health Equity Now ™ platform1, will launch in Columbus, Ohio, and be conducted in partnership with the National Center for Urban Solutions (NCUS), a Columbus-based organization focused on providing solutions in workforce development, education and wellness. The program seeks to

Diabetes requires management 24 hours a day, seven days a week, 365 days of the year and presents numerous daily challenges, particularly for families of young children and for adolescents and young adults with type 1 diabetes (T1D). Continuous glucose monitors (CGMs) can help young persons and families monitor glucose levels in real time, alerting them to a possible need for treatment adjustments. Today, two studies about the use of CGMs in pediatric and young adult populations were presented in the “Joint ADA/JDRF Symposium – Continuous Glucose Monitoring in Pediatric Diabetes — Ready for

Today, the American Diabetes Association ® (ADA) sent a letter to congressional leadership urging action on legislation to increase transparency in prescription drug rebates and prevent pharmacy benefit manager (PBM) practices from inflating the cost of prescription drugs. “Drug middlemen function at the center of the pharmaceutical supply chain and have virtually unparalleled power to affect drug costs, acting as intermediaries between insurers, manufacturers, and pharmacies,” according to the letter. Drug manufacturers often pay PBMs rebates on their drugs in exchange for coverage, limiting